Skip to content
10-Q

Quarterly Report

Goldenwell Biotech, Inc. GWLL

0001477932-25-008837

← back to feed
Filed
Dec 8, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Dec 5, 2025 99M sh
Shares Diluted Q3 2025 · Sep 30, 2025 96.43M sh
Shares Diluted Q3 2025 · Sep 30, 2025 96.43M sh
Shares Diluted Q3 2025 · Sep 30, 2024 96.43M sh
Shares Diluted Q3 2025 · Sep 30, 2024 96.43M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$3.78K
Operating Cash Flow restated Q3 2025 · Sep 30, 2024 −$97.73K
Stockholders Equity Q3 2025 · Sep 30, 2025 −$94.82K
Stockholders Equity Q3 2025 · Jun 30, 2025 −$86.84K
Stockholders Equity Q3 2025 · Mar 31, 2025 −$81.62K
Stockholders Equity Q3 2025 · Dec 31, 2024 −$47.24K
Stockholders Equity restated Q3 2025 · Sep 30, 2024 $19.24K
Stockholders Equity Q3 2025 · Jun 30, 2024 $3.83K
Stockholders Equity Q3 2025 · Mar 31, 2024 $53.75K
Stockholders Equity Q3 2025 · Dec 31, 2023 $84.72K
Current Liabilities Q3 2025 · Sep 30, 2025 $39.36K
Current Liabilities Q3 2025 · Dec 31, 2024 $1.86K
Total Liabilities Q3 2025 · Sep 30, 2025 $315.23K
Total Liabilities Q3 2025 · Dec 31, 2024 $271.43K
Total Assets Q3 2025 · Sep 30, 2025 $220.41K
Total Assets Q3 2025 · Dec 31, 2024 $224.19K
Net Income Q3 2025 · Sep 30, 2025 −$7.99K
Net Income Q3 2025 · Jun 30, 2025 −$5.22K
Net Income Q3 2025 · Mar 31, 2025 −$34.38K
Net Income restated Q3 2025 · Sep 30, 2024 $23.07K
Net Income restated Q3 2025 · Jun 30, 2024 $49.92K
Net Income restated Q3 2025 · Mar 31, 2024 $30.98K
Operating Income Q3 2025 · Sep 30, 2025 −$5.89K
Operating Income Q3 2025 · Sep 30, 2025 −$41.28K
Operating Income restated Q3 2025 · Sep 30, 2024 −$20.97K
Operating Income restated Q3 2025 · Sep 30, 2024 −$99.76K
Gross Profit Q3 2025 · Sep 30, 2025 $25K
Gross Profit Q3 2025 · Sep 30, 2025 $62.5K
Gross Profit Q3 2025 · Sep 30, 2024 $0
Gross Profit Q3 2025 · Sep 30, 2024 $149
Cost Of Revenue Q3 2025 · Sep 30, 2025 $0
Cost Of Revenue Q3 2025 · Sep 30, 2025 $0
Cost Of Revenue Q3 2025 · Sep 30, 2024 $0
Cost Of Revenue Q3 2025 · Sep 30, 2024 $148